{"title":"青春期抑制和性别肯定激素治疗的效果取决于年轻跨性别青少年先前的青春期发育程度。","authors":"Pierluigi Diana, Kirpal Adu-Gyamfi, Gary Butler","doi":"10.1159/000548004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>It is not known whether the extent of pubertal development influences the treatment effects in very young transgender people undergoing puberty suppression (PS) and gender-affirming hormone therapy (GAHT). This study aimed to investigate how anthropometric parameters and body composition change according to birth-assigned sex and affirmed gender during PS and GAHT.</p><p><strong>Methods: </strong>This retrospective study included data from 201 adolescents starting PS under 15yr at a national gender service (139 trans boys and 62 trans girls). Data from 127 of them who subsequently received GAHT were available. Height, weight, BMI, total lean, fat and muscle mass (LM, FM and MM) were collected using Tanita body composition analyzer.</p><p><strong>Results: </strong>'In puberty' trans boys (Tanner stage 2-3), total FM increased on PS (2.49 kg, 95% CI 1.66;3.33) similarly to LM (2.41 kg, 95% CI 1.85;2.97), while in 'completing puberty' trans boys (Tanner stage 4-5) the increase of total FM (1.80 kg, 95% CI 1.21;2.39) was higher than total LM (0.97 kg, 95% CI 0.63;1.30). 'In puberty' trans boys showed increasing mean FM z-scores from baseline after 3 years of PS (from 0.70 to 1.2). Mean LM z-scores decreased in both 'in puberty' (from 0.98 to 0.5) and 'completing puberty' (from 1.16 to 0.80) trans boys. During GAHT, 'in puberty' trans boys showed a greater increase of total LM and MM (respectively 6.28 kg, 95% CI 3.54;9.02 and 6.08 kg, 95% CI 3.64;8.51). Both groups 'in puberty' and 'completing puberty' trans boys did not show a further increase in total FM. In contrast, 'completing puberty' trans girls showed the greatest increase of total FM during PS (4.27 kg, 95% CI 1.50;7.03). MM and LM % decreased throughout PS in all trans girls, whereas body composition only changed slightly during GAHT.</p><p><strong>Conclusions: </strong>The effect of PS on body composition is more pronounced in 'in puberty' trans adolescents, and 'in puberty' trans boys are more responsive to GAHT, showing greater increases in MM and LM. In trans girls, the most significant increase in FM, along with reduction in LM and MM, occurs during PS, whereas no substantial changes were observed during subsequent GAHT. This suggests that any effect on physical performance may depend on pubertal development at the start of intervention.</p>","PeriodicalId":13025,"journal":{"name":"Hormone Research in Paediatrics","volume":" ","pages":"1-19"},"PeriodicalIF":2.7000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of puberty suppression and gender affirming hormone treatment depends upon prior extent of pubertal development in young transgender adolescents.\",\"authors\":\"Pierluigi Diana, Kirpal Adu-Gyamfi, Gary Butler\",\"doi\":\"10.1159/000548004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>It is not known whether the extent of pubertal development influences the treatment effects in very young transgender people undergoing puberty suppression (PS) and gender-affirming hormone therapy (GAHT). This study aimed to investigate how anthropometric parameters and body composition change according to birth-assigned sex and affirmed gender during PS and GAHT.</p><p><strong>Methods: </strong>This retrospective study included data from 201 adolescents starting PS under 15yr at a national gender service (139 trans boys and 62 trans girls). Data from 127 of them who subsequently received GAHT were available. Height, weight, BMI, total lean, fat and muscle mass (LM, FM and MM) were collected using Tanita body composition analyzer.</p><p><strong>Results: </strong>'In puberty' trans boys (Tanner stage 2-3), total FM increased on PS (2.49 kg, 95% CI 1.66;3.33) similarly to LM (2.41 kg, 95% CI 1.85;2.97), while in 'completing puberty' trans boys (Tanner stage 4-5) the increase of total FM (1.80 kg, 95% CI 1.21;2.39) was higher than total LM (0.97 kg, 95% CI 0.63;1.30). 'In puberty' trans boys showed increasing mean FM z-scores from baseline after 3 years of PS (from 0.70 to 1.2). Mean LM z-scores decreased in both 'in puberty' (from 0.98 to 0.5) and 'completing puberty' (from 1.16 to 0.80) trans boys. During GAHT, 'in puberty' trans boys showed a greater increase of total LM and MM (respectively 6.28 kg, 95% CI 3.54;9.02 and 6.08 kg, 95% CI 3.64;8.51). Both groups 'in puberty' and 'completing puberty' trans boys did not show a further increase in total FM. In contrast, 'completing puberty' trans girls showed the greatest increase of total FM during PS (4.27 kg, 95% CI 1.50;7.03). MM and LM % decreased throughout PS in all trans girls, whereas body composition only changed slightly during GAHT.</p><p><strong>Conclusions: </strong>The effect of PS on body composition is more pronounced in 'in puberty' trans adolescents, and 'in puberty' trans boys are more responsive to GAHT, showing greater increases in MM and LM. In trans girls, the most significant increase in FM, along with reduction in LM and MM, occurs during PS, whereas no substantial changes were observed during subsequent GAHT. This suggests that any effect on physical performance may depend on pubertal development at the start of intervention.</p>\",\"PeriodicalId\":13025,\"journal\":{\"name\":\"Hormone Research in Paediatrics\",\"volume\":\" \",\"pages\":\"1-19\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormone Research in Paediatrics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000548004\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone Research in Paediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548004","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:目前尚不清楚青春期发育程度是否影响非常年轻的变性人接受青春期抑制(PS)和性别肯定激素治疗(GAHT)的治疗效果。本研究旨在探讨PS和GAHT期间出生性别和确认性别对人体测量参数和身体组成的影响。方法:本回顾性研究包括201名在国家性别服务中心开始PS的15岁以下青少年的数据(139名变性男孩和62名变性女孩)。其中127名后来接受了GAHT治疗。采用Tanita体成分分析仪采集身高、体重、BMI、总瘦、脂肪和肌肉质量(LM、FM和MM)。结果:“青春期”变性男孩(Tanner阶段2-3)在PS上的总FM增加(2.49 kg, 95% CI 1.66;3.33)与LM (2.41 kg, 95% CI 1.85;2.97)相似,而“完成青春期”变性男孩(Tanner阶段4-5)的总FM增加(1.80 kg, 95% CI 1.21;2.39)高于LM (0.97 kg, 95% CI 0.63;1.30)。“青春期”变性男孩在经过3年的PS治疗后,其FM z-分数的平均值较基线有所增加(从0.70增加到1.2)。变性男孩在“青春期”(从0.98降至0.5)和“完成青春期”(从1.16降至0.80)的LM平均z分数均有所下降。在GAHT期间,“青春期”变性男孩的LM和MM总量增加更大(分别为6.28 kg, 95% CI 3.54;9.02和6.08 kg, 95% CI 3.64;8.51)。两组“处于青春期”和“完成青春期”的变性男孩的总FM没有进一步增加。相比之下,“完成青春期”的变性女孩在PS期间的总FM增加最多(4.27 kg, 95% CI 1.50;7.03)。在整个PS过程中,所有跨性别女孩的MM和LM百分比都有所下降,而在GAHT期间,身体成分仅略有变化。结论:PS对“青春期”跨性别青少年体成分的影响更为明显,“青春期”跨性别男孩对GAHT的反应更明显,MM和LM的增加幅度更大。在变性女孩中,最显著的FM增加,以及LM和MM的减少发生在PS期间,而在随后的GAHT期间没有观察到实质性的变化。这表明对身体表现的任何影响可能取决于干预开始时的青春期发育。
Effect of puberty suppression and gender affirming hormone treatment depends upon prior extent of pubertal development in young transgender adolescents.
Background: It is not known whether the extent of pubertal development influences the treatment effects in very young transgender people undergoing puberty suppression (PS) and gender-affirming hormone therapy (GAHT). This study aimed to investigate how anthropometric parameters and body composition change according to birth-assigned sex and affirmed gender during PS and GAHT.
Methods: This retrospective study included data from 201 adolescents starting PS under 15yr at a national gender service (139 trans boys and 62 trans girls). Data from 127 of them who subsequently received GAHT were available. Height, weight, BMI, total lean, fat and muscle mass (LM, FM and MM) were collected using Tanita body composition analyzer.
Results: 'In puberty' trans boys (Tanner stage 2-3), total FM increased on PS (2.49 kg, 95% CI 1.66;3.33) similarly to LM (2.41 kg, 95% CI 1.85;2.97), while in 'completing puberty' trans boys (Tanner stage 4-5) the increase of total FM (1.80 kg, 95% CI 1.21;2.39) was higher than total LM (0.97 kg, 95% CI 0.63;1.30). 'In puberty' trans boys showed increasing mean FM z-scores from baseline after 3 years of PS (from 0.70 to 1.2). Mean LM z-scores decreased in both 'in puberty' (from 0.98 to 0.5) and 'completing puberty' (from 1.16 to 0.80) trans boys. During GAHT, 'in puberty' trans boys showed a greater increase of total LM and MM (respectively 6.28 kg, 95% CI 3.54;9.02 and 6.08 kg, 95% CI 3.64;8.51). Both groups 'in puberty' and 'completing puberty' trans boys did not show a further increase in total FM. In contrast, 'completing puberty' trans girls showed the greatest increase of total FM during PS (4.27 kg, 95% CI 1.50;7.03). MM and LM % decreased throughout PS in all trans girls, whereas body composition only changed slightly during GAHT.
Conclusions: The effect of PS on body composition is more pronounced in 'in puberty' trans adolescents, and 'in puberty' trans boys are more responsive to GAHT, showing greater increases in MM and LM. In trans girls, the most significant increase in FM, along with reduction in LM and MM, occurs during PS, whereas no substantial changes were observed during subsequent GAHT. This suggests that any effect on physical performance may depend on pubertal development at the start of intervention.
期刊介绍:
The mission of ''Hormone Research in Paediatrics'' is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini reviews, clinical guidelines and papers on novel insights from clinical practice. Periodic editorials from outstanding paediatric endocrinologists address the main published novelties by critically reviewing the major strengths and weaknesses of the studies.